Literature DB >> 1376638

An endothelial ligand for L-selectin is a novel mucin-like molecule.

L A Lasky1, M S Singer, D Dowbenko, Y Imai, W J Henzel, C Grimley, C Fennie, N Gillett, S R Watson, S D Rosen.   

Abstract

The adhesive interaction between circulating lymphocytes and the high endothelial venules (HEV) of lymph nodes (LN) is mediated by lymphocyte L-selectin, a member of the selectin family of cell adhesion proteins. Previous work has identified a sulfated 50 kd glycoprotein (Sgp50) as an HEV ligand for L-selectin. We now report the purification of this glycoprotein and the utilization of the derived N-terminal amino acid sequence to clone a cDNA. The predicted sequence reveals a novel, mucin-like molecule containing two serine/threonine-rich domains. The mRNA encoding this glycoprotein is preferentially expressed in LN. Antibodies against predicted peptides immunoprecipitate Sgp50 and stain the apical surface of LN HEV. These results thus define a tissue-specific mucin-like endothelial glycoprotein that appears to function as a scaffold that presents carbohydrates to the L-selectin lectin domain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376638     DOI: 10.1016/0092-8674(92)90612-g

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  131 in total

1.  Endothelial ligands for L-selectin: from lymphocyte recirculation to allograft rejection.

Authors:  S D Rosen
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 2.  Adhesion molecule cascades direct lymphocyte recirculation and leukocyte migration during inflammation.

Authors:  D A Steeber; T F Tedder
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  Novel anti-carbohydrate antibodies reveal the cooperative function of sulfated N- and O-glycans in lymphocyte homing.

Authors:  Jotaro Hirakawa; Koichiro Tsuboi; Kaori Sato; Motohiro Kobayashi; Sota Watanabe; Atsushi Takakura; Yasuyuki Imai; Yuki Ito; Minoru Fukuda; Hiroto Kawashima
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

Review 4.  L-Selectin ligands in lymphoid tissues and models of inflammation.

Authors:  Adil I Khan; R Clive Landis; Rajneesh Malhotra
Journal:  Inflammation       Date:  2003-10       Impact factor: 4.092

5.  Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions.

Authors:  J Fernandez-Rodriguez; O Dwir; R Alon; G C Hansson
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

6.  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.

Authors:  Espen S Baekkevold; Myriam Roussigné; Takeshi Yamanaka; Finn-Eirik Johansen; Frode L Jahnsen; François Amalric; Per Brandtzaeg; Monique Erard; Guttorm Haraldsen; Jean-Philippe Girard
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

7.  Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates.

Authors:  E Ioffe; P Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  Characterization of porcine intestinal receptors for the K88ac fimbrial adhesin of Escherichia coli as mucin-type sialoglycoproteins.

Authors:  A K Erickson; D R Baker; B T Bosworth; T A Casey; D A Benfield; D H Francis
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Monocyte-endothelial adhesion in chronic rheumatoid arthritis. In situ detection of selectin and integrin-dependent interactions.

Authors:  J S Grober; B L Bowen; H Ebling; B Athey; C B Thompson; D A Fox; L M Stoolman
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Higher-affinity oligosaccharide ligands for E-selectin.

Authors:  R M Nelson; S Dolich; A Aruffo; O Cecconi; M P Bevilacqua
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.